Zydus Lifesciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, revenue was INR 141,413 million compared to INR 123,757 million a year ago. Net income was INR 26,772 million compared to INR 16,637 million a year ago. Basic earnings per share from continuing operations was INR 26.25 compared to INR 16.39 a year ago. Diluted earnings per share from continuing operations was INR 26.25 compared to INR 16.39 a year ago. Basic earnings per share was INR 26.45 compared to INR 16.36 a year ago. Diluted earnings per share was INR 26.45 compared to INR 16.36 a year ago.